Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Tango Therapeutics (TNGX) Operating Margin (2020 - 2025)

Tango Therapeutics (TNGX) has 6 years of Operating Margin data on record, last reported at 1287.87% in Q2 2025.

  • For Q2 2025, Operating Margin fell 113918.0% year-over-year to 1287.87%; the TTM value through Jun 2025 reached 647.37%, down 33580.0%, while the annual FY2025 figure was 178.39%, 16769.0% up from the prior year.
  • Operating Margin reached 1287.87% in Q2 2025 per TNGX's latest filing, down from 788.76% in the prior quarter.
  • Across five years, Operating Margin topped out at 4.24% in Q2 2021 and bottomed at 1287.87% in Q2 2025.
  • Average Operating Margin over 5 years is 465.35%, with a median of 434.56% recorded in 2022.
  • Peak YoY movement for Operating Margin: surged 27745bps in 2023, then plummeted -113918bps in 2025.
  • A 5-year view of Operating Margin shows it stood at 384.6% in 2021, then fell by -24bps to 476.79% in 2022, then plummeted by -35bps to 644.69% in 2023, then crashed by -54bps to 993.68% in 2024, then decreased by -30bps to 1287.87% in 2025.
  • Per Business Quant database, its latest 3 readings for Operating Margin were 1287.87% in Q2 2025, 788.76% in Q1 2025, and 993.68% in Q4 2024.